Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 2|浏览32

暂无评分

摘要

•Patients with IDH-mutated AML who undergo nonmyeloablative allogeneic transplant in CR1 with post-transplant cyclophosphamide have better OS than those with IDH-wildtype AML.•Among patients with IDH-mutated AML, patients who received a peritransplant IDH inhibitor had improved OS compared to patients who did not.

查看译文

关键词

Acute myeloid leukemia,Isocitrate dehydrogenase mutations,Isocitrate dehydrogenase inhibitors,Bone marrow transplant,Outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要